Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

BMS Licenses Kai Heart Drug For $227 Million

13 May 2008

• By Jessica Merrill

Delta protein kinase C inhibitor was given up by Daiichi Sankyo in 2007.

Related Content

Bristol’s Goal: 2 New Biologics/Year In Clinic – R&amp;D Chief

06 Dec 2007

Adnexus Buy Aimed At Enhancing Bristol’s Transformation To Biopharma Business

24 Sep 2007

Bristol Sells ConvaTec Wound Care For $4.1 Billion

05 May 2008

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.